Insiders who reported open-market trades in the last 12 months at the companies Jason B. Daly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
John Kiely - $882K in AMRX purchases and sales in the last 12 months
Ted C. Nark - $586K in AMRX purchases and sales in the last 12 months
Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jason B. Daly is a corporate insider, tracked as EVP, Chief Legal Officer of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason B. Daly submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jason B. Daly been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($4.46M) across all tracked filings.
Jason B. Daly is EVP, Chief Legal Officer of Amneal Pharmaceuticals, Inc. (AMRX). 6 SEC Form 4 filings on record going back to 2024, most recently on 13 August 2026. Most recent open-market trade: sold $3.65M of AMRX on 13 August 2026. Lifetime open-market sales: $4.46M.
Recent transactions
15
The latest 15 SEC Form 4 transactions reported by Jason B. Daly.
InsiderAlpha's records for Jason B. Daly go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
